US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 4.330
  • +0.010+0.23%
Close Nov 21 16:00 ET
  • 4.330
  • 0.0000.00%
Post 20:01 ET
37.45MMarket Cap-1011P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lumos Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 150.000K--
--2024/Q4-- / 5.328M--
--2024/Q3726.000K / 253.250K--
Aug 1, 20242024/Q2488.000K / 202.600K--
May 15, 20242024/Q1165.000K / 378.250K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 150.000K--
--2024/Q4-- / 5.328M--
--2024/Q3726.000K / 253.250K--
Aug 1, 20242024/Q2488.000K / 202.600K--
May 15, 20242024/Q1165.000K / 378.250K--

Unlock Free Earnings Estimates

Lumos Pharma Earnings Reports

  • Lumos Pharma | 10-Q: Q3 2024 Earnings Report

    Nov 7 15:13 ET

  • Lumos Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 2 08:19 ET

  • Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update

    Aug 1 17:12 ET

  • Lumos Pharma | 10-Q: Q1 2024 Earnings Report

    May 15 22:40 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 2, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data